Discovery contributes to future treatment of cervical cancer

December 4, 2015, National University of Singapore
The molecular mechanism for the action of HPV E6, the HPV oncogene, on proteins EDD1 and TIP60. HPV E6 binds with EDD1 to ubiquitinate TIP60, leading to the degradation of TIP60, eventually resulting in tumor tumorigenesis. Credit: National University of Singapore

A team of scientists from Cancer Science Institute of Singapore (CSI Singapore) at the National University of Singapore (NUS) has uncovered new molecular interactions involved in the development of cervical cancer. Proteins EDD1 and TIP60 were found to interact with the Human Papilloma Virus (HPV), which causes cervical cancer in humans. EDD1 is an E3 ubiquitin ligase involved in degrading cellular proteins, while TIP60 act as a tumor suppressor protein, and can both be found in the human body.

The research team, comprising Assistant Professor Sudhakar Jha, Dr Vanitha K. Subbaiah and Mr Zhang Yanzhou, found that HPV E6 oncogene interacts with EDD1 to destabilise the TIP60 protein, thereby resulting in an increased tumorigenesis. In support of this finding, experiments also revealed that an increase in cellular TIP60 levels could inhibit .

The findings of the study were first published online in the journal Oncogene on 3 August 2015.

Previous studies have implicated the roles of both EDD1 and TIP60 in , however their roles in viral-mediated cancers have not been well-explored. Notably, this study is one the few which explores the functional role of TIP60 in viral-mediated cancers. It is also the first to suggest EDD1 as a novel interacting partner of TIP60, a finding which advances the understanding of how this pathway could contribute to progression not only in , but also in many other cancer types such as breast and ovarian cancer.

Oncoviruses (cancer-causing viruses) are said to account for about 12% of new cancer cases annually. Cervical cancer, which is the cancer of the cervix, accounts for about 8% of all cancer cases worldwide and is the fourth most common cause of cancer and deaths from cancer in women. Infections with cancer-causing viruses such as HPV are a major health burden worldwide, and contribute significantly to patient mortality. Availability of prophylactic vaccines hold promises in the prevention of the disease, but unfortunately does not help already-infected patients.

Said Asst Prof Jha, "We are excited about this discovery. Understanding how the two proteins interact with HPV E6 oncogene is a critical first step towards developing methods to target HPV-induced cancers as there is no specific treatment available at the moment. Our team is currently developing methods that can be used to screen small molecule inhibitors of EDD1 and also looking into how the regulation of TIP60 levels can be translated into therapeutic advances for the treatment of viral-mediated cancers such as cervical cancer. If successful, this could potentially be a significant breakthrough."

Explore further: Stress responder is a first responder in helping repair DNA damage and avoiding cancer

More information: V K Subbaiah et al. E3 ligase EDD1/UBR5 is utilized by the HPV E6 oncogene to destabilize tumor suppressor TIP60, Oncogene (2015). DOI: 10.1038/onc.2015.268

Related Stories

Stress responder is a first responder in helping repair DNA damage and avoiding cancer

August 3, 2015
DNA damage increases the risk of cancer, and researchers have found that a protein, known to rally when cells get stressed, plays a critical, early step in its repair.

Cures and curcumin: Turmeric offers potential therapy for oral cancers

April 24, 2015
Turmeric—the familiar yellow spice common in Indian and Asian cooking—may play a therapeutic role in oral cancers associated with human papillomavirus, according to new research published in ecancermedicalscience.

Schoolgirl cancer vaccination encourages mothers to attend cervical screening

November 12, 2015
Manchester researchers have shown that the introduction of the HPV vaccination programme for girls has increased uptake for cervical cancer screening by their mothers.

Some types of papilloma virus might prevent cervical cancer

April 10, 2013
(Medical Xpress)—Certain types of papilloma virus might actually prevent cervical cancer, according to a new study by researchers from The University of Manchester.

New research opens door to understanding human tonsil cancer



November 2, 2015
Researchers at Simon Fraser University and the BC Cancer Agency have developed a groundbreaking method to identify and separate stem cells that reside in the tonsils. Their research, which sheds new light on the fight against ...

Recommended for you

New 'SLICE' tool can massively expand immune system's cancer-fighting repertoire

November 15, 2018
Immunotherapy can cure some cancers that until fairly recently were considered fatal. In addition to developing drugs that boost the immune system's cancer-fighting abilities, scientists are becoming expert at manipulating ...

Standard chemotherapy treatment for HPV-positive throat cancer remains the most effective, study finds

November 15, 2018
A new study funded by Cancer Research UK and led by the University of Birmingham has found that the standard chemotherapy used to treat a specific type of throat cancer remains the most effective.

Anti-malaria drugs have shown promise in treating cancer, and now researchers know why

November 15, 2018
Anti-malaria drugs known as chloroquines have been repurposed to treat cancer for decades, but until now no one knew exactly what the chloroquines were targeting when they attack a tumor. Now, researchers from the Abramson ...

Researchers identify a mechanism that fuels cancer cells' growth

November 14, 2018
Scientists at the UCLA Jonsson Comprehensive Cancer Center have identified sodium glucose transporter 2, or SGLT2, as a mechanism that lung cancer cells can utilize to obtain glucose, which is key to their survival and promotes ...

A new approach to detecting cancer earlier from blood tests: study

November 14, 2018
Cancer scientists led by principal investigator Dr. Daniel De Carvalho at Princess Margaret Cancer Centre have combined "liquid biopsy", epigenetic alterations and machine learning to develop a blood test to detect and classify ...

New antibody breakthrough to lead the fight against cancer

November 14, 2018
Scientists at the University of Southampton have developed a new antibody that could hold the key to unlocking cancer's defence against the body's immune system.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.